Gabler, Lisa
Lötsch, Daniela
Kirchhofer, Dominik
van Schoonhoven, Sushilla
Schmidt, Hannah M.
Mayr, Lisa
Pirker, Christine
Neumayer, Katharina
Dinhof, Carina
Kastler, Lucia
Azizi, Amedeo A.
Dorfer, Christian
Czech, Thomas
Haberler, Christine
Peyrl, Andreas
Kumar, Rajiv
Slavc, Irene
Spiegl-Kreinecker, Sabine
Gojo, Johannes http://orcid.org/0000-0002-8113-3416
Berger, Walter
Funding for this research was provided by:
Fellinger Krebsforschung (2017)
Oesterreichische Nationalbank (15173)
Innovative Medicines Initiative (ITCC-P4)
Austrian Science Fund (P30105, T906)
Ă–sterreichischen Akademie der Wissenschaften (DOC-Fund)
Article History
Received: 24 June 2019
Accepted: 18 July 2019
First Online: 7 August 2019
Ethics approval and consent to participate
: The study was approved by the ethics committee of the Medical University of Vienna and by the local ethics committee of Upper Austria in Linz. Informed consent was obtained from all participating patients and/or legal representatives.
: Not applicable.
: The authors declare that they have no competing interests.